Prognostic significance of macrophage marker in leiomyosarcomas. Lee C, Espinosa I, Vrijaldenhoven S, Subramanian S, Montgomery K, Zhu S, Poulin N, Nielsen T, West R, Gilks B, van de Rijn M. Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone. Lee C, Espinosa I, Jensen K, Subramanian S, Zhu S, Varma S, Montgomery K, Nielsen TO, van de Rijn M and West R. Lubieniecka JM, de Bruijn D, Su L,van Dijk A, Subramanian S, van de Rijn M, Poulin N, van Kessel A,Nielsen TO.Histone deacetylase inhibitors reverse SS18-SSX mediated polycomb silencing of the tumor suppressor EGR1 in synovial sarcoma. MicroRNA expression signature of human soft tissue tumors Oncogene 2008 27:2015-2016 Subramanian S, Lui WO, Lee CH, Espinosa E, Nielsen T, Heinrich M, Corless C, Fire A, and van de Rijn M. Intraepithelial T cells and prognosis in ovarian carcinoma: Novel associations with stage, tumor type and BRCA1 loss. BMC Med 2009 7:9.Ĭlarke B, Tinker AV, Lee C, Subramanian S, van de Rijn M, Turbin D, Cadungog MG, Huntsman D, Coukos G, Gilks CB. A compact VEGF signature associated with distant metastases and poor outcomes. Hu Z, Fan C, Livasy C, He X, Oh DS, Ewend MG, Carey LA, Subramanian S, West R, Ikpatt F, Olopade OI, van de Rijn M, Perou CM. Genome-wide transcriptional profiling reveals microRNA-correlated genes and pathways in human lymphoblastoid cell lines. ![]() Wang L, Oberg AL, Asmann YW, Sicotte H, McDonnell SK, Riska SM, Liu W, Steer CJ, Subramanian S, Cunningham JM, Cerhan JR and Thibodeau SN. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. Sarver AL, French A, Borralho PM, Thayanithy V, Silverstein K, Morlan B, Oberg A, Cunningham J, Subramanian S, Wang L, Rodrigues C, Thibodeau SN, Steer CJ. MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation carrying high-grade serous carcinomas of ovary. Lee CH, Subramanian S, Beck AH, Espinosa I, Senz J, Zhu S, Huntsman D, van de Rijn M, Gilks C. Gene networks and microRNAs implicated in aggressive prostate cancer. ![]() Wang L, Tang H, Thayanithy T, Subramanian S, Oberg AL, Cunningham JM, Cerhan JR, Steer CJ, Thibodeau SN. MicroRNAs in cardiovascular diseases: Biology and potential clinical applications. Genome-wide transcriptome analyses reveals p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumors. Subramanian S, Thayanithy V, West RB, Lee CH, Beck AH, Zhu S, Downs-Kelly E, Montgomery K, Goldblum JR, Hogendoorn PCW, Corless CL, Oliveira AM, Dry SM, Nielsen TO, Rubin BP, Fletcher JA, Fletcher CDM, van de Rijn M. S-MED: Sarcoma microRNA Expression Database. ![]() Sarver A, Phalak R, Thayanithy V, Subramanian S. MicroRNAs identified in highly purified nuclei from HCT116 colon cancer cells. Park C, Zeng Y, Zhang X, Subramanian S and Steer CJ. miR-183 functions as a potential oncogene by targeting EGR1 and promoting tumor cell migration. ![]() Regulation of Heme-Oxygenase-1 protein expression by miR-377 in combination with miR-217. Speaker invited by Ola Myklebost, Tumor Biologyīeckman JD, Chen C, Nguyen J, Thayanithy V, Subramanian S, Steer CJ, and Vercellotti GM. MicroRNA mediated gene regulation in human sarcomas gene expression profilesdeveloping novel diagnostic markers and identification of therapeutic targets in sarcomas and other cancers.įor more information, see Dr. Research Program: Genetic Mechanisms of CancerĪssistant Professor, Department of Interests
0 Comments
Leave a Reply. |